Literature DB >> 20510314

Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells.

Sarah Wulhfard1, Lucia Baldi, David L Hacker, Florian Wurm.   

Abstract

Valproic acid (VPA) is a small molecule that inhibits histone deacetylase activity. Here we report that VPA increases recombinant mRNA and protein levels in transiently transfected CHO DG44 cells. In the presence of VPA, transient recombinant antibody yields of up to 40 mg/L were achieved in simple batch cultures. The steady-state levels of the IgG light and heavy chain mRNAs were nearly 10 times higher than in the untreated control transfection even though the level of transfected plasmid DNA was the same in the presence or absence of VPA. The combination of VPA treatment and incubation of the transfected cells in mildly hypothermic conditions resulted in recombinant antibody yields of over 90 mg/L by 6 days post-transfection in batch cultures. The results demonstrated that the treatment of transfected CHO DG44 cells with VPA is a cost-effective strategy for enhancing transient gene expression by increasing the transgene mRNA levels. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510314     DOI: 10.1016/j.jbiotec.2010.05.003

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  11 in total

1.  Enhanced CHO cell-based transient gene expression with the epi-CHO expression system.

Authors:  Joe Codamo; Trent P Munro; Benjamin S Hughes; Michael Song; Peter P Gray
Journal:  Mol Biotechnol       Date:  2011-06       Impact factor: 2.695

2.  Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers.

Authors:  William C Yang; Jiuyi Lu; Ngan B Nguyen; An Zhang; Nicholas V Healy; Rashmi Kshirsagar; Thomas Ryll; Yao-Ming Huang
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

3.  High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.

Authors:  Volker Jäger; Konrad Büssow; Andreas Wagner; Susanne Weber; Michael Hust; André Frenzel; Thomas Schirrmann
Journal:  BMC Biotechnol       Date:  2013-06-26       Impact factor: 2.563

4.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

5.  Network reconstruction of the mouse secretory pathway applied on CHO cell transcriptome data.

Authors:  Anne Mathilde Lund; Christian Schrøder Kaas; Julian Brandl; Lasse Ebdrup Pedersen; Helene Faustrup Kildegaard; Claus Kristensen; Mikael Rørdam Andersen
Journal:  BMC Syst Biol       Date:  2017-03-15

6.  Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells.

Authors:  Xiaotian T Fang; Dag Sehlin; Lars Lannfelt; Stina Syvänen; Greta Hultqvist
Journal:  Biol Proced Online       Date:  2017-09-15       Impact factor: 3.244

7.  Continuous Online Protein Quality Monitoring during Perfusion Culture Production Using an Integrated Micro/Nanofluidic System.

Authors:  Taehong Kwon; Sung Hee Ko; Jean-François P Hamel; Jongyoon Han
Journal:  Anal Chem       Date:  2020-03-24       Impact factor: 6.986

8.  Immortalizing Mesenchymal Stromal Cells from Aged Donors While Keeping Their Essential Features.

Authors:  María Piñeiro-Ramil; Rocío Castro-Viñuelas; Clara Sanjurjo-Rodríguez; Silvia Rodríguez-Fernández; Tamara Hermida-Gómez; Francisco J Blanco-García; Isaac Fuentes-Boquete; Silvia Díaz-Prado
Journal:  Stem Cells Int       Date:  2020-06-16       Impact factor: 5.443

9.  Effect of Peptone Feeding on Transient Gene Expression Process in CHO DG44.

Authors:  Fatemeh Davami; Farnaz Eghbalpour; Farzaneh Barkhordari; Fereidoun Mahboudi
Journal:  Avicenna J Med Biotechnol       Date:  2014-07

10.  Addition of a histone deacetylase inhibitor increases recombinant protein expression in Medicago truncatula cell cultures.

Authors:  Rita B Santos; Ana Sofia Pires; Rita Abranches
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.